Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak
Evaluation of Rehabilitation Experiences of Physiotherapists in Covid-19 Outbreak
研究概览
详细说明
The aim of this study is to evaluate the process experienced by physiotherapists while providing rehabilitation services during the epidemic and to investigate the procedures adopted by physiotherapists who are currently working.
In addition, by analyzing the effects of both the pandemic and the clinical and educational organizations in the Physiotherapy and Rehabilitation Clinics where physiotherapists were working during the COVID-19 epidemic, the needs arising after the pandemic can be reported.
Assessments will be carried out by researcher physiotherapists through a questionnaire based on research and examples in the literature, and scales measuring anxiety, depression and stress levels. The measurement tool will be the online survey application.
Data collection is planned to take place in February-March 2021.
Surveys will be distributed via WhatsApp, e-mail, social media links. This questionnaire was sent to 3 physiotherapists and subjected to a pre-test. This questionnaire is about the following situations and contains 37 questions:
Information on employment status: In this section, physiotherapists' name-surname, gender, age, professional practice experience (years), generally applied physiotherapy subgroup (more than one can be selected), whether they are self-employed or employees, and the status of performing face-to-face clinical practices will be questioned. If so, it will be questioned which protection measures have been applied.
Information about tele-rehabilitation practices: In this section, it will be questioned whether physiotherapists start to follow their patients remotely, if they are, in what way they do it, whether the number of weekly sessions continues, and whether the amount collected is the same as the face-to-face amount.
General information about COVID 19 rehabilitation: In this section, did the departments where physiotherapists work returned to COVID 19 services, did they work in COVID 19 units, rehabilitation approaches in COVID 19 patients, protocol and / or guidelines on exercises for rehabilitation management and treatment of COVID 19 patients. material development / implementation status will be questioned.
The impact of the pandemic on the health and teaching activities of physiotherapists and the sustainability of clinical / thesis studies during this period will be questioned.
Finally, the CES Depression Scale (Center for Epidemiologic Studies Depression Scale, CES-D) will be used to determine depression level, the Generalized Anxiety Disorder 7 (GAD-7) Test will be used to evaluate generalized anxiety level, Perceived Stress Scale (PSS) will be used to determine stress level.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
Beykoz
-
Istanbul、Beykoz、火鸡、34815
- Medipol University
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.
Exclusion Criteria:
Not meeting the inclusion criteria
学习计划
研究是如何设计的?
设计细节
- 观测模型:队列
- 时间观点:追溯
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Physiotherapists
Individuals between the ages of 22-65 who continue to work as a self-employed or employee physiotherapist.
|
Participants will be evaluated by applying a questionnaire and scales created by the researcher physiotherapists based on the researches and examples in the literature.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
A questionnaire created by research physiotherapists based on researches and examples in the literature.
大体时间:The evaluation will take place in one interview (the interview will take 30 minutes)
|
Participants will be evaluated by applying a questionnaire and scales created by the researcher physiotherapists based on the researches and examples in the literature.
|
The evaluation will take place in one interview (the interview will take 30 minutes)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Assessment of depression level with Center for Epidemiologic Studies Depression Scale
大体时间:The evaluation will take place in one interview (the interview will take 30 minutes)
|
The Center for Epidemiologic Studies Depression Scale will be used to determine depression level.
The scale consists of 20 questions in the form of a self-report that measure the emotional state of the person in depression, perceptions and behaviors towards depression.
4-point Likert type questionnaire with 0-60 points range is encoded in 0-3 points range.
|
The evaluation will take place in one interview (the interview will take 30 minutes)
|
|
Assessment of anxiety level with Generalized Anxiety Disorder 7 Test
大体时间:The evaluation will take place in one interview (the interview will take 30 minutes)
|
The Generalized Anxiety Disorder 7 test will be used to determine anxiety level.
It is a 7-item four-point Likert (0 = none, 1 = many days, 2 = more than half of the days, 3 = almost every day), which evaluates the experiences asked in the scale items in the last 2 weeks.
The total scores obtained from the scale are 5, 10, and 15 cut-off points for mild, moderate, and severe anxiety, respectively.
|
The evaluation will take place in one interview (the interview will take 30 minutes)
|
|
Assessment of stress level with Perceived Stress Scale
大体时间:The evaluation will take place in one interview (the interview will take 30 minutes)
|
Perceived Stress Scale will be used to determine stress level.
Participants rate how often their lives were seen as unpredictable, uncontrollable, and overly intense during the previous month on the 5-point Likert scale (0 = Never, 4 = Very often).
Total scores range from 0 to 40, with higher scores indicating a higher perceived stress level.
|
The evaluation will take place in one interview (the interview will take 30 minutes)
|
合作者和调查者
调查人员
- 学习椅:Gülay Aras Bayram, asAss. Prof.、Medipol University
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- E-10840098-772.02-2682
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
在美国制造并从美国出口的产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.